Redefining the Future of Bioprocessing

VectorisBio is transforming bioprocessing with breakthrough chromatography technologies and AI-driven molecular design and docking. Our platform creates tailored, chemically defined ligands for the purification of today’s most advanced biologics.

These AI-enabled ligands deliver unmatched specificity, purity, and scalability—helping our partners accelerate development, streamline manufacturing, and reduce costs. From early-stage R&D to full-scale GMP production, our technologies empower the life sciences sector to bring critical therapies to market faster and more reliably.

As demand grows for biologics, cell and gene therapies, and next-generation protein therapeutics, VectorisBio is building the next-generation biomanufacturing platform—where innovation, scalability, and accessibility redefine what’s possible in life-saving medicine.

A scientist working in a laboratory, holding a pipette and wearing blue gloves, working with test tubes and laboratory equipment.
Close-up of a healthcare professional using a pipette in a laboratory setting, wearing blue gloves and a white lab coat, with various laboratory supplies in the background.
A scientist wearing blue gloves and a white lab coat is holding a pipette with yellow liquid, transferring it into a test tube.
A scientist working in a laboratory with green laser beams visible inside a specialized enclosed chamber.
A scientist wearing a lab coat, glasses, and blue gloves working with a laboratory machine in a sterile environment.
A scientist wearing a white lab coat, blue gloves, and glasses is working in a laboratory. The scientist is holding a green-capped test tube or sample container, with laboratory equipment and supplies visible on the work surface.
A detailed 3D model of a virus particle, showing a spherical core surrounded by multiple spike-like structures.

HA-Ferritin model structure used for design of ligand

Our Technology

At VectorisBio, we are building the next generation of purification platforms for viral vectors and complex biologics. Our technology integrates AI-driven molecular design and docking with advanced synthetic chemistry to engineer ligands that set new standards in selectivity, scalability, and performance.

AI-Enabled Ligand Discovery

By applying artificial intelligence to predict molecular interactions, we rapidly explore chemical space and design ligands with exceptional binding precision. This accelerates discovery timelines while ensuring high reproducibility and cost efficiency compared to conventional screening methods.

Tailored Affinity Ligands

Our ligands are chemically defined, customisable, and GMP-compatible, offering a transformative alternative to traditional chromatography approaches. They deliver consistent performance across scales—from early-stage R&D to full commercial manufacturing.

Scalable Bioprocessing Solutions

VectorisBio’s purification platforms are designed to meet the evolving demands of biologics, vaccines, and cell and gene therapies. By improving yields, purity, and process robustness, we help our partners bring therapies to patients faster and at lower cost.